Results 181 to 190 of about 11,049 (220)

Refractory status epilepticus

Current Opinion in Critical Care, 2005
Although conventional anticonvulsant agents can terminate status epilepticus in most cases, a substantial minority of patients develops medically refractory status and requires more aggressive care. This review explores the options available.Increasing numbers of previously unexpected etiologies for refractory status epilepticus continue to be reported.
openaire   +2 more sources

Neuromodulation in Super-refractory Status Epilepticus

Journal of Clinical Neurophysiology, 2021
Summary: Status epilepticus (SE) is a severe condition that needs immediate pharmacological treatment to tackle brain damage and related side effects. In approximately 20% of cases, the standard treatment for SE does not control seizures, and the condition evolves to refractory SE.
Ioannis, Stavropoulos, Ho Lim, Pak, Antonio, Valentin   +2 more
openaire   +2 more sources

Epilepsy, Status Epilepticus, and Refractory Status Epilepticus

2017
Epilepsy is a common nervous system disease that affects approximately 65 million people worldwide. Because it has diverse clinical manifestations, epilepsy is difficult to diagnose and treat. In contrast to epilepsy, status epilepticus (SE) is not self-terminating.
Yangmei Chen, Shichuo Li
openaire   +1 more source

Isoflurane for Refractory Status Epilepticus

Anesthesiology, 1989
General anesthesia has been recommended to control convulsive status epilepticus that is refractory to conventional anticonvulsant therapy. Halothane has been the recommended agent, but without experimental justification. Isoflurane, which has no reported organ toxicity and produces electrographic suppression at clinically useful concentrations in ...
Kofke, W. A., Young, R. S., Davis, P., Woelfel, S. K., Gray, L., Johnson, D., Gelb, A., Meeke, R., Warner, D. S., Pearson, K. S., Gibson Jr., J. R., Koncelik, J., Wessel, H. B.   +12 more
openaire   +5 more sources

Role of Propofol in Refractory Status Epilepticus

Annals of Pharmacotherapy, 1998
OBJECTIVE: To provide a review of the proposed mechanism of action, clinical efficacy, adverse effects, and therapeutic considerations associated with the use of propofol in the management of patients with refractory status epilepticus. DATA SOURCES:
L A, Brown, G M, Levin
openaire   +2 more sources

Electroencephalographic Reporting for Refractory Status Epilepticus

Journal of Clinical Neurophysiology, 2019
Purpose: We aimed to determine whether clinical EEG reports obtained from children in the intensive care unit with refractory status epilepticus could provide data for comparative effectiveness research studies. Methods: We conducted a retrospective descriptive study to assess the ...
Arnold J, Sansevere, Ravindra, Arya, Iván, Sánchez Fernández, William D, Gaillard, Robert C, Tasker, Yi-Chen, Lai, Anne E, Anderson, Dmitry, Tchapyjnikov, Kevin E, Chapman, J Nicholas, Brenton, Jessica L, Carpenter, Marina, Gaínza-Lein, Joshua L, Goldstein, Howard P, Goodkin, Michele C, Jackson, Kush, Kapur, Mohamad A, Mikati, Katrina, Peariso, Tracy A, Glauser, Alexis A, Topjian, Mark, Wainwright, Angus A, Wilfong, Korwyn L, Williams, Tobias, Loddenkemper, Nicholas S, Abend   +24 more
openaire   +2 more sources

Neurosurgical Treatment of Refractory Status Epilepticus

Epilepsia, 1992
Summary: Refractory status epilepticus (RSE) is defined as status epilepticus that continues despite aggressive treatment. A 9.8‐year‐old boy with a past history of daily left focal motor seizures was transferred to University of California at Los Angeles (UCLA) Hospital in pentobarbital coma after 4 days in RSE.
D G, Gorman, W D, Shields, D A, Shewmon, H T, Chugani, R, Finkel, Y G, Comair, W J, Peacock   +6 more
openaire   +2 more sources

Lacosamide for the Treatment of Refractory Status Epilepticus

Annals of Pharmacotherapy, 2011
Objective: To evaluate current evidence for the use of lacosamide in the treatment of refractory status epilepticus. Data Sources: Literature was accessed via PubMed (through July 2011) using the terms lacosamide and status epilepticus.
Erica M, Fernandez, Andrew J, Franck
openaire   +2 more sources

Interferon-Associated Refractory Status Epilepticus

Pediatrics, 1994
Interferons have been used since the early 1980s for their antiviral, antiproliferative, and immunomodulatory actions to treat a variety of oncologic, infectious, and autoimmune disorders. Although many patients experience mild neurologic adverse effects with the administration of interferon, serious neurologic adverse effects are uncommon.1 We report ...
V S, Miller, R J, Zwiener, B A, Fielman
openaire   +2 more sources

The use of topiramate in refractory status epilepticus

Neurology, 2004
To the Editor: Towne et al. reported the use of topiramate in refractory status epilepticus (SE).1 It was particularly interesting in Patient 3. Her SE was initially controlled by lorazepam, …
Andrew, Tarulli, Francis W, Drislane
openaire   +2 more sources